Mercedes Iñarrairaegui

Author

Also Known As

Francesco Izzo, Iñarrairaegui, Mercedes, M Iñarrairaegui, M Iñarrairaegui Bastarrica, M. Inarrairaegui, M. Iñarrairaegui, M. Iñarrairaegui Bastarrica, Mercedes Iarrairaegui, Mercedes Inarrairaegui, Mercedes Iñarrairaegui

187

Publications

10.5K

Citations

H-Index

Concepts

All Affiliations

Clinica Universidad de Navarra Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Universidad de Navarra Navarre Institute of Health Research Universitat de Barcelona

About

Mercedes Iñarrairaegui is an author at Clinica Universidad de Navarra specializing in medicine, hepatology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	29	3.4K
2	Hepatology	18	25	3.3K
3	Health Sciences	12	13	910
4	Immunology	11	11	2.2K
5	Cell Biology	1	1	16

Mercedes Iñarrairaegui

Publications

9.3K

Citations

H-Index

Page 1

	Year	Citations
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade Philip J. Johnson, Sarah Berhane, Chiaki Kagebayashi, Journal of Clinical Oncology	2014	2.6K
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy María Reig, Zoe Mariñó, Christie Perelló, Journal of Hepatology HepatologyHepatitis CHcv-related HccViral HepatitisHigh Rate	2016	1K
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C Bruno Sangro, Carlos Gómez-Martín, Manuel de la Mata, Journal of Hepatology HepatologyViral HepatitisMedicineImmunologyPathology	2013	977
Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation Bruno Sangro, L Carpanese, Roberto Cianni, Hepatology	2011	648
Liver disease induced by radioembolization of liver tumors Bruno Sangro, Belén Gil-Alzugaray, Javier Rodríguez, Cancer	2008	359
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients Jordi Colmenero, Manuel Rodríguez‐Perálvarez, Magdalena Salcedo, Journal of Hepatology	2020	317
Prognostic factors and prevention of radioembolization-induced liver disease Belén Gil-Alzugaray, Á. Chopitea, Mercedes Iñarrairaegui, Hepatology	2012	267
Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma Bruno Sangro, José Ignacio Bilbao, José Boán, International Journal of Radiation OncologyBiologyPhysics HepatologyHepatocellular CarcinomaMedicineRadiopharmaceutical TherapyLiver Cancer	2006	215
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis Jesús M. Bañales, Mercedes Iñarrairaegui, Ander Arbelaiz, Hepatology	2018	182
Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade Hidenori Toyoda, Paul B.S. Lai, James O’Beirne, British Journal of Cancer	2016	172

Page 1